AKBA - Akebia Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$4.00
DETAILS
HIGH:
$4.00
LOW:
$4.00
MEDIAN:
$4.00
CONSENSUS:
$4.00
UPSIDE:
189.86%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Laffont | 375,954 | $522,576 | 0.0% | +375,954 | NEW |
| Greenblatt | 27,172 | $37,769 | 0.0% | +11,202 | INCREASED |
| Cooperman | 16,106 | $22,387 | -- | +584 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-29 | Ostrowski Erik | officer: SVP, CFO, CBO & Treasurer | SELL | 56,019 | $1.11 | $62K |
| 2026-06-17 | Wolf Myles | director | A-Award | 53,600 | $1.02 | $55K |
| 2026-06-17 | ROGERS MICHAEL W | director | A-Award | 35,700 | -- | -- |
| 2026-06-17 | FRIESON RON | director | A-Award | 53,600 | $1.02 | $55K |
| 2026-06-17 | ZUMWALT LEANNE M | director | A-Award | 35,700 | -- | -- |
| 2026-06-17 | Wolf Myles | director | A-Award | 35,700 | -- | -- |
| 2026-06-17 | Smith Cynthia | director | A-Award | 35,700 | -- | -- |
| 2026-06-17 | Smith Cynthia | director | A-Award | 53,600 | $1.02 | $55K |
| 2026-06-17 | ROGERS MICHAEL W | director | A-Award | 53,600 | $1.02 | $55K |
| 2026-06-17 | FRIESON RON | director | A-Award | 35,700 | -- | -- |
| 2026-06-17 | ADAMS ADRIAN | director | A-Award | 35,700 | -- | -- |
| 2026-06-17 | ADAMS ADRIAN | director | A-Award | 53,600 | $1.02 | $55K |
| 2026-06-17 | ZUMWALT LEANNE M | director | A-Award | 53,600 | $1.02 | $55K |
| 2026-04-01 | Vickers Philip J. | director | A-Award | 214,400 | $1.41 | $302K |
| 2026-04-01 | Vickers Philip J. | ? | -- | -- | -- | |
| 2026-03-04 | Butler John P. | director, officer: CEO and President | BUY | 69,270 | $1.25 | $87K |
| 2026-02-02 | Malabre Richard C | officer: SVP, Chief Accounting Officer | SELL | 36,142 | $1.39 | $50K |
| 2026-02-02 | Malabre Richard C | officer: SVP, Chief Accounting Officer | SELL | 13,382 | $1.39 | $19K |
| 2026-02-02 | Burke Steven Keith | officer: SVP, Chief Medical Officer | SELL | 20,701 | $1.39 | $29K |
| 2026-02-02 | Rucci Carolyn M. | officer: SVP, Chief Legal Officer | SELL | 25,382 | $1.39 | $35K |
| 2026-02-02 | Butler John P. | director, officer: CEO and President | SELL | 46,660 | $1.39 | $65K |
| 2026-02-02 | Butler John P. | director, officer: CEO and President | SELL | 114,891 | $1.39 | $160K |
| 2026-02-02 | Rucci Carolyn M. | officer: SVP, Chief Legal Officer | SELL | 16,846 | $1.39 | $23K |
| 2026-02-02 | Grund Nicholas | officer: Chief Commercial Officer | SELL | 31,244 | $1.39 | $43K |
| 2026-02-02 | Burke Steven Keith | officer: SVP, Chief Medical Officer | SELL | 25,375 | $1.39 | $35K |